Metabolic studies in Wilson's disease: Evaluation of efficacy of chelation therapy in respect to copper balance
- 31 July 1971
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 51 (1) , 31-40
- https://doi.org/10.1016/0002-9343(71)90321-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- New Oral Chelating Agent for Treatment of Wilson's DiseaseNature, 1966
- Hepatolenticular degeneration: The comparative effectiveness of D-penicillamine, potassium sulfide, and diethyldithiocarbamate as decoppering agentsThe Journal of Pediatrics, 1966
- Hepatolenticular degeneration: Observations on a case treated with d-penicillamineThe Journal of Pediatrics, 1963
- Metabolic balance studies in hepatolenticular degeneration treated with diethyldithiocarbamateThe American Journal of Medicine, 1963
- The long term management of hepatolenticular degeneration (Wilson's disease)The American Journal of Medicine, 1960
- Penicillamine, a new oral therapy for Wilson's diseaseThe American Journal of Medicine, 1956
- The place of bal in the therapy of Wilson's diseaseThe American Journal of Medicine, 1956
- WILSON'S DISEASE: NEW ORAL THERAPYThe Lancet, 1956
- Studies on Copper Metabolism. XIII. Hepatolenticular Degeneration1Journal of Clinical Investigation, 1954
- Genetic and biochemical aspects of Wilson's diseaseThe American Journal of Medicine, 1953